Search our
Current Studies
This is a Phase 3 randomized double-blind placebo controlled study Assessing the Efficacy and Safety of Anti-Spike SARS-CoV-2 Monoclonal Antibodies in Preventing SARS-Cov-2 Infection in Household Contacts of Individuals Infected with SARS-CoV-2
Location(s): Jacksonville (Headquarters)
Condition: COVID-19
This is a Phase 2a study being done to evaluate the efficacy, safety, PK, and immunogenicity of multiple doses of MEDI3506 in adult subjects with DKD.
Location(s): Jacksonville- LaVilla (Downtown)
Condition:
This study is being done to assess the efficacy and safety of tirzepatide compared to dulaglutide in patients with type 2 diabetes and increased cardiovascular risk.
Location(s): Jacksonville- LaVilla (Downtown), Macon
Condition: Diabetes, Heart Disease
This is a randomized, double-blind, placebo-controlled study to assess the safety, tolerability, efficacy, PK, and PD of the chimeric dopamine-somatostatin receptor agonist, TBR-760, in adult patients with non-functioning pituitary adenomas over 52 weeks
Location(s): Jacksonville (Headquarters)
Condition: Non-Functioning Pituitary Adenoma
ECO-RESET: is a Randomized, Double-Blind, Placebo-Controlled, Multiple Dose, Multi-center study to assess the efficacy and safety of SER‑287 in adults with active mild-to-moderate ulcerative colitis
Location(s): St. Augustine
Condition: Ulcerative Colitis
PRECISION: The study is to evaluate the blood pressure lowering effect of aprocitentan when added to other anti-hypertensive drugs of patients with difficult to control (resistant) high blood pressure (hypertension), and to show that blood pressure reduction is kept for long period of time.
Location(s): St. Augustine
Condition: Resistant Hypertension
This randomized, double-blind, placebo controlled, parallel group study being done to provide data on the efficacy, safety, tolerability and pharmacokinetics of multiple dose of PF-06882961 in adults with type 2 diabetes mellitus that are inadequately controlled on metformin and/or diet and exercise.
Location(s): Jacksonville (Headquarters), Jacksonville- LaVilla (Downtown), Macon
Condition: Diabetes
DELIVER Double-blind, Randomized, Placebo-Controlled Phase III Study to Evaluate the Effect of Dapagliflozin on Reducing CV Death or Worsening Heart Failure in Patients with Heart Failure with Preserved Ejection Fraction (HFpEF)
Location(s): St. Augustine
Condition: Heart Failure
Protocol I8F-MC-GPHR(a) A Randomized, Double-Blind, Placebo-Controlled Phase 2 Study Comparing the Efficacy and Safety of Tirzepatide versus Placebo in Patients with Nonalcoholic Steatohepatitis (NASH)
Location(s): Jacksonville- LaVilla (Downtown)
Condition: Nonalcoholic Steatohepatitis
The NODE-303 Study: Multi-Centre, Multi-National,Open Label, …
Location(s): St. Augustine
Condition:
SELECT – Semaglutide Effects on Cardiovascular Outcomes in People With Overweight or Obesity
Location(s): Jacksonville (Headquarters)
Condition: Heart Disease
A Phase 2b, Multicentre, Randomised, Double-blind, Placebo-controlled Study of Verinurad and Allopurinol in Patients With Chronic KIdney Disease and Hyperuricaemia
Location(s): Jacksonville- LaVilla (Downtown)
Condition: Kidney Disease
A Double-blind Randomized Placebo-controlled Trial Assessing the Effects of Inclisiran on Clinical Outcomes Among People With Atherosclerotic Cardiovascular Disease
Location(s): Jacksonville (Headquarters), Jacksonville- LaVilla (Downtown), Lake CIty, Macon, St. Augustine
Condition: Cholesterol, Heart Disease
A Research Study to Look at How Semaglutide Compared to Placebo Affects Diabetic Eye Disease in People With Type 2 Diabetes (FOCUS)
Location(s): Jacksonville (Headquarters)
Condition: Diabetes
A Multicentre International Randomized Parallel Group Double-blind Placebo-controlled Clinical Trial of EMPAgliflozin Once Daily to Assess Cardio-renal Outcomes in Patients With Chronic KIDNEY Disease
Location(s): Jacksonville (Headquarters), Jacksonville- LaVilla (Downtown), Lake CIty, Macon
Condition: Kidney Disease